期刊文献+

大黄素对小鼠结肠癌CT26.WT细胞的抑制作用 被引量:1

The inhibiting effects of emodin on mice colon cancer CT26. WT cells in vitro
下载PDF
导出
摘要 目的探讨大黄素对小鼠结肠癌细胞CT26.WT的抑制作用。方法 MTT法检测大黄素对结肠癌细胞CT26.WT增殖的抑制作用;细胞划痕实验检测大黄素对结肠癌细胞CT26.WT迁徙的抑制作用;流式细胞仪检测大黄素对结肠癌细胞CT26.WT表达CC族趋化因子受体4(CCR4)和叉头蛋白3(Foxp3)的影响。结果大黄素明显抑制CT26.WT细胞的增殖,加入的大黄素浓度越高抑制效果越好(P<0.05);大黄素抑制CT26.WT细胞的迁徙,抑制效果随浓度升高而愈加明显(P<0.01);大黄素抑制CT26.WT细胞的Foxp3表达,而表达CCR4的肿瘤细胞的比例同样低于不加药组,这种抑制作用与大黄素的药物浓度呈负相关(P<0.01)。结论大黄素抑制小鼠结肠癌的CT26.WT细胞增殖,Foxp3和CCR4在CT26.WT细胞的表达降低,可能是大黄素抑制其迁徙的原故。 Objective To investigate the mechanism of emodin in inhibiting of CT26.WT cell line.Methods The proliferation and migration capacities of CT26.WT cells were assessed by MTT method and scratch assay,respectively;while the expression of CCR4 and Foxp3 was assessed by flow cytometry.Results Significant inhibition of cell proliferation and migration of CT26.WT was observed by Emodin in a concentration-dependent manner(P 0.05);so was the down-regulation of Foxp3 and CCR4(P 0.01).Conclusion Emodin inhibits the CT26.WT cell proliferation and migration,which is probably via the down-regulation of CCR4 and Foxp3.
出处 《广东医学》 CAS CSCD 北大核心 2013年第12期1797-1800,共4页 Guangdong Medical Journal
基金 广东省中医药局建设中医药强省立项资助科研课题(编号:20121104)
关键词 大黄素 结肠癌细胞株CT26 WT Foxp3 CCR4 Emodin the CT26.WT cell line Foxp3 CCR4
  • 相关文献

参考文献14

  • 1LU Y, YANG J H, LI X, et al. Emodin, a naturally occurring an- thraquinone derivative, suppresses IgE - mediated anaphylactic re- action and mast cell activation[ J]. Biochem Pharmacol, 2011,82 (11) : 1700 - 1708.
  • 2XIONG H R, LUO J, HOU W, et al. The effect of emodin, an anthraquinone derivative extracted from the roots of rheum tangutic- um, against herpes simplex virus in vitro and in vivo[ J]. J Ethno- pharmacol, 2011, 133(2) : 718 -723.
  • 3GUO J, XIAO B, LIU Q, et al. Suppression of C - myc expres- sion associates with anti - proliferation of aloe - emodin on gastric cancer cells[ J ]. Cancer Invest, 2008, 26 (4) : 369 - 374.
  • 4WANG Chun - guang, YANG Jun - qing, LIU Bei - zhong, et al.Anti -tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo [ J ]. Eur J Pharma- col, 2010, 627(1/3) : 33 -41.
  • 5HUANG Q, LU G, SHEN H M, et al. Anti - cancer properties of anthraquinones from rhubarb [ J ]. Med Res Rev, 2007, 27 (5) : 609 - 630.
  • 6OK S, KIM S M, KIM C, et al. Emodin inhibits invasion and mi- gration of prostate and lung cancer cells by downregulating the ex- pression of chemokine receptor CXCR4 [ J ]. Immunopharmacol Immunotoxicol, 2012, 34(5): 768-778.
  • 7DIMITRAKOPOULOS F I, PAPADAKI H, ANTONACOPOULOU A G, et al. Association of FOXP3 expression with non - small cell lung cancer[ J ]. Anticancer Res, 2011, 31 (5) : 1677 - 1683.
  • 8刘干,黄琨,李惠.皮肤鳞癌及癌前病变中Foxp3蛋白的表达[J].重庆医科大学学报,2011,36(6):660-663. 被引量:1
  • 9XUE L, LU H Q, HE J, et al. Expression of FOXP3 in esophage- al squamous cell carcinoma relating to the clinical data [ J ]. Dis Esophagus, 2010, 23(4): 340-346.
  • 10ISHIDA T, UEDA R. CCR4 as a novel molecular target for immu- notherapy of cancer[J]. Cancer Sci, 2006, 97 ( 11 ) : 1139 - 1146.

二级参考文献25

  • 1Pascale Quatresooz,Claudine Pierara-Franehimont,Philippe Paquet,et al.Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues[J].EurJ Dermatol, 2008,18 ( 1 ): 6-10.
  • 2Sakaguchi S,Sakaguchi N,Shimizu J,et al.Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:their common role in controlling autoimmunity,tumor immunity,and transplantation tolerance[J].Immunol Rev,2001,182( 1 ):18-32.
  • 3Hori S, Nomura T, Sakaguchi S.Control of regulatory T cell devel- opment by the transcription factor Foxp3 [J].Science, 2003,299 (5609): 1057-1061.
  • 4Fontenot J D,Rasmussen J P,Williams L M,et al.Regulatory T ceil lineage specification by the forkbead transcription factor foxp3[J]. Immunity, 2005,22(3 ):329-341.
  • 5Lisa M.Eber,Bee Shin Tan,Judy Browning,et al.The Regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells [J].Cancer Res, 2008,68 (8):3001-3009.
  • 6Sebastian Hinz, Laia Pagerols-Raluy, Hans-Heinrich Oberg,et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer[J].Cancer Res,2007,67(17):8344-8350.
  • 7Xue L,Lu H Q,He J,et al.Expression of FOXP3 in esophagial squamous cell carcinoma relating to the clinical data[J].Dis Esophagus, 2010,23(4):340-346.
  • 8Zou W.Immunosuppressive networks in the tumour environment and their therapeutic relevance[J].Nat Rev Cancer, 2005,5 (4) :263-274.
  • 9Shevach E M,DiPaolo R A,Andersson J,et al.The lifestyle of naturally occurring CD4+CD25+ Foxp3+ regulatory T cells[J].Immunol Rev, 2006,212( 1 ):60-73.
  • 10Brunkow M E,Jeffery E W,Hjerrild K A,et al.Disruption of a new forkhead/winged-helix protein,seurfin,results in thefatal lymphoproliferative disorder of the seurfy mouse[J].Nat.Genet, 2001,27( 1 ):68-73.

同被引文献14

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部